"Integrated Chemotherapeutic Reprogramming and Targeted Senotherapeutic Clearance Elicits Near-Complete (80–89%) Restoration of Youthful Multi-Omic Profiles and Systemic Physiological Resilience."

Integrated Chemotherapeutic Reprogramming and Targeted Senotherapeutic Clearance: A Transformative Anti-Aging Framework At the forefront of next-generation biomedical innovation, Nabinjyoti Behera, Founder of NAFVNA Pharmaceuticals, presents a groundbreaking and highly ambitious therapeutic paradigm designed to redefine the limits of human aging, systemic resilience, and cellular regeneration. Rooted in multidisciplinary expertise spanning Environmental Toxicology, Pharmaceutical Chemistry, and Mutation Virology, this research proposes a unified, whole-body rejuvenation system that moves beyond conventional anti-aging strategic